Wells Fargo
SZYM

Wells Fargo’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Wells Fargo’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-46,913
Closed -$95K – 6626
2016
Q1 		$95K Buy
46,913
+9,230
+24% +$16.5K ﹤0.01% 4866
2015
Q4 		$93K Sell
37,683
-4,880
-11% -$14.5K ﹤0.01% 4966
2015
Q3 		$110K Sell
42,563
-3,080
-7% -$8.03K ﹤0.01% 4815
2015
Q2 		$144K Buy
45,643
+28,550
+167% +$97.9K ﹤0.01% 4802
2015
Q1 		$49K Buy
17,093
+4,784
+39% +$12.2K ﹤0.01% 5018
2014
Q4 		$32K Sell
12,309
-3,725
-23% -$16.3K ﹤0.01% 5195
2014
Q3 		$119K Sell
16,034
-936
-6% -$8.74K ﹤0.01% 4588
2014
Q2 		$201K Buy
16,970
+5,356
+46% +$57.1K ﹤0.01% 4376
2014
Q1 		$135K Buy
11,614
+300
+3% +$3.53K ﹤0.01% 4525
2013
Q4 		$123K Buy
11,314
+280
+3% +$2.75K ﹤0.01% 4457
2013
Q3 		$119K Sell
11,034
-285,464
-96% -$3.25M ﹤0.01% 4416
2013
Q2 		$3.48M Buy
+296,498
New +$2.96M ﹤0.01% 2397

Wells Fargo's SZYM Position: Q2 2016 in Review

Wells Fargo sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 46,913 shares — an estimated $95K sold.

Wells Fargo first reported a position in SZYM in Q2 2013 and held it in 12 quarters. The position peaked at $3.48M in Q2 2013. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

  • Wells Fargo reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Wells Fargo sold 46,913 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $95K.
  • Wells Fargo first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
  • Wells Fargo's SOLAZYME INC COM STK (DE) position peaked at $3.48M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on Wells Fargo's 13F filing for Q2 2016, filed 11 Aug 2016.